Promoting research in biological, medical and pharmaceutical areas in support of the development of innovative and safe medicines for everyone in Europe
Innovative study designs and research methods are crucial in the current framework for new effective drugs identification and development covering serious and unmet medical needs of special population
Life science and new technologies’ advancements, such as Artificial Intelligence, are crucial to improve the patients’ life, however at the same time the highest level ethical rules have to be met and regulations continuously updated
Data Science application has a key role in the progress enhancement in pharmaceutical and health products field. Keeping pace with the progress require that all research data are Findable-Accessible-Interoperable-Reusable
Patients, including also those affected by rare diseases, are a relevant part of the research efforts and are entitled to have an easy and fast access to any scientific results that could improve their expectancy and quality of life
Improving the patient involvement, in all the steps of the research and development process, can impact on patients' needs and disease outcomes. Raising awareness is a key point to engage patients and citizens in the healthcare field
fondazione per la ricerca farmacologica
gianni benzi onlus
Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus is a Scientific Research Organisation, registered as a private, not-for-profit Foundation in 2007, with the aim to promote research in biological, medical and pharmaceutical areas in support of the development of innovative and safe medicines in Europe.
Discover more about us through this video.
Delve into some of the most important activities now running at Fondazione Gianni Benzi
Keep updated on all the initiatives and events of the Gianni Benzi Onlus Foundation dedicated to the comparison of research and training topics.
CRO in Aviano and 6 italian partners will organise a two-day event on 11-17 October 2023, focused on Technology Transfer, Health Technology Assessment and Innovation Procurement
The European Medicines Agency (EMA) is looking for new data partners to collaborate with DARWIN EU® – the Data Analysis and Real-World Interrogation Network.
EMA published a draft reflection paper on the use of artificial intelligence to support the safe and effective development, regulation and use of human and veterinary medicines.
In July 2023, the European Commission adopted its Implementing Decision on the adequate level of protection of personal data under the EU-US Data Privacy Framework (Adequacy Decision).